Serotonin is a medical spa franchise offering anti-aging services including cosmetic injectables, hormone replacement therapy, and IV infusions. The franchise is in very early stages with only 11 units total and concerning unit performance - 6 of 12 units opened in 2024 were terminated. The business requires significant capital investment ($872K-$1.8M) and must comply with complex medical regulations including CPOM doctrine. Territory protection is strong with exclusive 3-mile radius, but the high termination rate and early-stage system present significant risks for potential franchisees.
Generated from 2025 Franchise Disclosure Document
AI-generated from FDD analysis — use as a checklist with your attorney
Total startup costs, working capital, and financial requirements
Training, marketing support, technology, and operational assistance
Royalty, marketing, technology, and other ongoing fees
Revenue data, P&L estimates, and financial projections
Lawsuits, disputes, and legal risk assessment
Territory rights, term length, non-compete, and transfer rules
82 legal provisions scored on a franchisee-friendliness scale
Unit growth trends, exit rates, and system trajectory
Similar to Serotonin in category and investment range